Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial

BACKGROUND: Currently, coronavirus disease 2019 (COVID-19) is continuously and rapidly circulating, causing heavy damage on public health. No effective antiviral treatment has been proved thus far. Traditional Chinese medicine (TCM) has been widely applied in the treatment of a variety of infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Bangjiang, Zhang, Wen, Wu, Xinxin, Huang, Tingrong, Li, Huacheng, Zheng, You, Che, Jinhua, Sun, Shuting, Jiang, Chao, Zhou, Shuang, Feng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312108/
https://www.ncbi.nlm.nih.gov/pubmed/32580752
http://dx.doi.org/10.1186/s13063-020-04498-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312108/
https://www.ncbi.nlm.nih.gov/pubmed/32580752
http://dx.doi.org/10.1186/s13063-020-04498-6

Ejemplares similares